NSC |
Compound |
Enrichment |
Correlation |
NSC 618770 |
Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide |
0.0208632511155816 |
0.3979755 |
NSC 645018 |
1,4-bis(N-Cysteinyldiethylamino)-5,8-dihydroxy anthraquinon |
0.0208632511155816 |
0.03656715 |
NSC 669884 |
Null |
0.0208632511155816 |
-0.0031857839 |
NSC 674258 |
Null |
0.0208632511155816 |
0.22765057 |
NSC 675004 |
Null |
0.0208632511155816 |
0.080642333 |
NSC 675772 |
Glutamic acid, N-[4-[[6-(trifluoromethyl)-2-quinoxalinyl] amino]benzoyl]-, diethyl ester |
0.0208632511155816 |
-0.048198011 |
NSC 683405 |
Null |
0.0208632511155816 |
0.066067779 |
NSC 697726 |
RH1 |
0.0208632511155816 |
0.26168807 |
NSC 709362 |
Acetamide, N,N'-(1,5-pentanediyl)bis[2-(1,3,5,11a-tetrahydro- 5-oxopyrrolo[2,1-c][1,4]benzodiazepin-2-ylidene)- |
0.0208632511155816 |
0.26466875 |
NSC 710530 |
Null |
0.0208632511155816 |
0.16873406 |